Juan F. Granada, MD
CRF-Skirball Center for Innovation, Cardiovascular Research Foundation,
Columbia University Medical Center, New York.
Local drug delivery is rapidly emerging as the first line of therapy for the interventional treatment of superficial femoral artery disease. Paclitaxel-eluting drug-coated balloons are emerging as a promising therapy.
From the International Symposium on Endovascular Therapies (ISET) Meeting, held February 4-8, 2017.
A summary of the research presented at the Amputation Prevention Symposium at the 2017 International Symposium on Endovascular Therapies (ISET) Meeting.
Sheshagiri Rao Damera, DM
Ramachandra Barik, MD
Department of Cardiology, Nizam’s Institute of Medical Sciences, Hyderabad, Telengana, India.
Balloon angioplasty of a critically or completely occluded segment of the aorta in Takayasu’s arteritis is challenging because of extensive panarteritis and diffuse fibrosis. We report the case of a 38-year-old female with aortoarteritis.
Luke Kim, MD1; Dmitriy N. Feldman, MD1; Daniel McCormick, DO2
From 1the Division of Cardiology/Department of Medicine, Weill Cornell Medical College, New York, New York; and 2Division of Cardiology/Department of Medicine, Pennsylvania Hospital, Philadelphia, Pennsylvania.
There is a growing interest in assessing carotid artery plaque morphology and composition in order to identify patients with vulnerable plaque. With rapid advances in imaging technology, characterizing plaque with novel modalities may help to underst…
Craig Walker, MD
Clinical Editor
Interventional Cardiologist
Founder, President, and Medical Director
Cardiovascular Institute of the South
Clinical Professor of Medicine
Tulane University School of Medicine
Louisiana State University School of Medicine